StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Chlorothiazid

Chlorothiazide

HCID 2720
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
58-94-6
Standard-SMILES
NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O
InChIKey
JBMKAUGHUNFTOL-UHFFFAOYSA-N
Summenformel
C7H6ClN3O4S2
Durchschnittliche Molmasse
295,7 g/mol
Monoisotopische Masse
294,9488257

Überblick

Crystals; white powder. (NTP, 1992)

Namen und Bezeichner

Bevorzugter Name
Chlorothiazide
IUPAC
6-chloro-1,1-dioxo-4H-1λ6,2,4-benzothiadiazine-7-sulfonamide
Lokaler Name
Chlorothiazid
Englischer Name
Chlorothiazide
Summenformel
C7H6ClN3O4S2
Molmasse
295.72

Namen und Synonyme

chlorothiazide58-94-6DiurilChlorthiazideChlorothiazidChlortiazidChlotrideFlumenChlorosalChloruritClotrideDiuresal
Weitere Namen anzeigen
ThiazideHydrochlorothiazide Impurity AUrinexDiupres
DiurilixSaluretilWarduzideAlureneDiuriteDiutridMinzilSalisan

Datenbank-Bezeichner

CAS
58-94-6
PubChem CID
2720
DTXSID
DTXSID0022800
ChEMBL
CHEMBL842
ChEBI
CHEBI:3640
UNII
77W477J15H
EC Number
200-404-9

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
-0,2
Polarare Oberfläche (TPSA)
135 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
1
Schwere Atome
17
Formalladung
0
Komplexität
532

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Metabolite of Hydrochlorthiazide

SpringerMaterials PropertiesCrystal structure
LogP · 3 Einträge

log Kow = -0.24

-0.5

-0.1

OdorODORLESS
Color/Form · 2 Einträge

Crystals

WHITE OR PRACTICALLY WHITE

Solubility · 5 Einträge

less than 1 mg/mL at 67.1 °F (NTP, 1992)

SOL IN WATER: 0 G/L @ PH 4, 0.65 G/L @ PH 7; SOL IN ALKALINE AQ SOLN

FREELY SOL IN DIMETHYLFORMAMIDE & DIMETHYL SULFOXIDE; SLIGHTLY SOL IN METHANOL & PYRIDINE; PRACTICALLY INSOL IN ETHER, BENZENE, & CHLOROFORM

3.98e-01 g/L

>44.4 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 4 Einträge

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Thiazide Diuretics

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H317 (99.7%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 344 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Other Safety InformationIMAP assessments - 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide: Human health tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 Eintrag

SYMPTOMS: Symptoms of exposure to this compound may include skin and mucous membrane irritation; pancreatitis, depression of the formed elements of the blood; purpura, photosensitive dermatitis, necrotizing vasculitis, hyperglycemia, aggravation of diabetes mellitus; exacerbation of renal and/or hepatic insufficiency; lethargy, potassium loss, hyperglycemia, hyperuricemia, coma, chloride loss, lethargy, muscle cramps, acidosis, skin rash, salivary gland obstruction, psychosis, convulsions, leukopenia, jaundice, excessive amount of calcium in the blood, acute glomerulonephritis, anorexia, nausea, vomiting, cramping, diarrhea, dizziness, constipation, vertigo, paresthesis, headache, xanthopsia, hemolytic anemia, urticuria, fever, respiratory distress, including pneumonitis and pulmonary edema, anaphylactic reactions, glycosuria, muscle spasm, weakness, transient blurred vision and restlessness.

FDA Requirements · 1 Eintrag

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingApproximately 40% bound to plasma proteins.
Pharmacodynamics · 1 Eintrag

Like other thiazides, chlorothiazide promotes water loss from the body (diuretics). It inhibits Na<sup>+</sup>/Cl<sup>-</sup> reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. Chlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosages, all thiazides are approximately equal in their diuretic efficacy. Chlorothiazide increases excretion of sodium and chloride in approximately equivalent amounts. Natriuresis may be accompanied by some loss of potassium and bicarbonate. After oral doses, 10-15 percent of the dose is excreted unchanged in the urine. Chlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.

Mechanism of Action · 6 Einträge

As a diuretic, chlorothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like chlorothiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of chlorothiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.

THE MECHANISM BY WHICH THIAZIDE DIURETICS LOWER BLOOD PRESSURE HAS NOT BEEN FIRMLY ESTABLISHED. /THIAZIDE DIURETICS/

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Antihypertensive medicines

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
DecompositionWhen heated to decomposition it emits very toxic fumes of sulfoxides, nitroxides, and /hydrogen chloride/.
Melting Point · 4 Einträge

648 to 649 °F (Decomposes) (NTP, 1992)

342.5-343

Decomposes at 342.5-343 °C

350 °C

Physical Description · 2 Einträge

Crystals; white powder. (NTP, 1992)

Solid

Dissociation Constants · 2 Einträge

6.85

pKa1 = 6.85; pKa2 = 9.45

Physikochemische Eigenschaften

Schmelzpunkt
342 · 342-343°C
Siedepunkt
608.8 · 608.8±65.0 °C(Predicted)
Dichte
1.7303 · 1.7303 (rough estimate)
Brechungsindex
1.61 · 1.6100 (estimate)
storage temp.
2 · 2-8°C
Löslichkeit
DMSO (Slightly), Methanol (Very Slightly, Heated)
Aggregatzustand
Solid
pka
6.85 · 6.85, 9.45(at 25℃)
Farbe
White to Off-White
Wasserlöslichkeit
0.1 g/100 · <0.1 g/100 mL at 19.5 ºC
Merck
14 · 14,2168
BCS Class
4 · 4
Stabilität
Stable. Incompatible with strong oxidizing agents.
Major Application
pharmaceutical (small molecule)
InChI
1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)
InChIKey
JBMKAUGHUNFTOL-UHFFFAOYSA-N
SMILES
O=S(C1=C2C=C(Cl)C(S(N)(=O)=O)=C1)(NC=N2)=O
LogP
-0.24 · -0.240
CAS Datenbank
58 · 58-94-6(CAS DataBase Reference)
NIST chemische Informationen
Chlorothiazide(58-94-6)
EPA chemische Informationen
Chlorothiazide (58-94-6)

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Reactive GroupAmines, Phosphines, and Pyridines
Reactivity ProfileAlkaline aqueous solutions will decompose on standing or heating (NTP, 1992).
Air and Water ReactionsInsoluble in water.
Hazard Classes and CategoriesSkin Sens. 1 (99.7%)

Sicherheit und Schutzausrüstung

Fire FightingFires involving this material can be controlled with a carbon dioxide, dry chemical or Halon extinguisher. (NTP, 1992)
First Aid · 1 Eintrag

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 Eintrag

SMALL SPILLS AND LEAKAGE: If you spill this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then dampen the solid spill material with toluene, then transfer the dampened material to a suitable container. Use absorbent paper dampened with toluene to pick up any remaining material. Your contaminated clothing and absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Solvent-wash all contaminated surfaces with toluene followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Personal Protective Equipment (PPE) · 1 Eintrag

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxikologische Informationen

Interactions · 5 Einträge

...IN DOG PRELOADED WITH SODIUM BICARBONATE, URINE EXCRETED AFTER ADMIN OF A THIAZIDE CONTAINS RELATIVELY MORE BICARBONATE THAN CHLORIDE. /BENZOTHIADIAZIDES/

USE OF ENTERIC-COATED COMBINATIONS OF POTASSIUM CHLORIDE & THIAZIDE... ASSOCIATED WITH A HIGH INCIDENCE OF ULCERATION OF DISTAL JEJUNUM OF ILEUM. /BENZOTHIADIAZIDES/

Concurrent use of thiazide diuretics with amiodarone may lead to an increased risk of arrhythmias associated with hypokalemia. /Thiazide diuretics/

Effects /of coumarin- or indandione-derivative anticoagulants/ may be decreased when used concurrently with thiazide diuretics as a result of reduction of plasma volume leading to concentration of procoagulant factors in the blood; in addition, diuretic-induced improvement of hepatic function resulting in increased procoagulant factor synthesis; dosage adjustments may be necessary. /Thiazide diuretics/

For more Interactions (Complete) data for CHLOROTHIAZIDE (16 total), please visit the HSDB record page.

Milk ConcentrationsChlorothiazide is excreted into breast milk in low concentrations.
Human Toxicity Excerpts · 5 Einträge

TWO SMALL CHILDREN...INGESTED TOTAL DOSE OF 15 G CHLOROTHIAZIDE BETWEEN THEM, PRESENTED WITH LETHARGY WHICH PROGRESSED TO DEEP COMA WITHIN 12 HR. BOTH RECOVERED WITHOUT SEQUELAE, & NEITHER CHILDREN EXHIBITED OBJECTIVE EVIDENCE OF FLUID OR ELECTROLYTE DISORDER. ...22-MO-OLD CHILD WHO INGESTED 3 G EXHIBITED LETHARGY.

FETAL OR NEONATAL EFFECT IS THROMBOCYTOPENIA. /FROM TABLE/

Maternal and fetal deaths in two cases of acute hemorrhagic pancreatitis were attributed to the use of chlorothiazide in the second and third trimesters.

In addition to diuresis and resultant dehydration, overdosage of thiazides may produce lethargy, nausea, weakness, and electrolyte imbalance; lethargy may progress to coma within a few hours with minimal depression of respiratory and cardiovascular function and without evidence of dehydration or serum electryolye change. The mechanism of thiazide-induced CNS depression is unknown. GI irritation and hypermotility may occur, and temporary elevation of the BUN has been reported. Serum electrolyte changes (e.g., hypokalemia, hypochloremia, hyponatremia) may occur, especially in patients with impaired renal function. /Thiazides/

May suppress lactation, but compatible /SRP: with breast feeding/. /Thiazide diuretics, from table/

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Chlorothiazide

vLess-DILI-concern

2

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity Excerpts · 2 Einträge

DOSES OF UP TO 5 G/KG /IN MONKEYS/ BY GAVAGE PRODUCED ONLY A TRANSIENT LETHARGY OF A MODERATE DEGREE.

HYPOCHLOREMIA HAS OCCURRED IN SOME DOGS WITH INCR BICARBONATE RETENTION & ALKALOSIS.

Antidote and Emergency TreatmentThiazide diuretic overdose should be treated by immediate evacuation of the stomach followed by supportive symptomatic treatment and monitoring of serum electrolyte concentrations and renal function. /Thiazide diuretic/
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Non-Human Toxicity Values · 5 Einträge

LD50Rat oral 10 g/kg

LD50 Rat ip 1386 mg/kg

LD50 Rat iv 200 mg/kg

LD50 Mouse oral 8 g/kg

For more Non-Human Toxicity Values (Complete) data for CHLOROTHIAZIDE (7 total), please visit the HSDB record page.

EPA Human Health Benchmarks for Pharmaceuticals · 6 Einträge

Chlorothiazide

11.7

49.3

The usual adult dosage is 0.5 g to 1 g once or twice a day.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 500 mg/day, Lowest Therapeutic Dose (LTD): 6.3 mg/kg-day, and Screening Dose: 0.002 mg/kg-day.

21-Jan-20

Regulatorische Informationen

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Sicherheitsdaten

wgk
2
tsca
TSCA listed
hs_code
2935904000
RTECS-Nr.
DK9450000
risk_code
42/43-20/21/22
hazard_code
Xn
safety_code
36
Speicherklasse
11 - Combustible Solids
Giftige Stoffe Daten
58-94-6(Hazardous Substances Data)
Hazard Classifications
Resp. Sens. 1Skin Sens. 1

...INDICATED THAT BENZOTHIADIAZIDES HAVE A DIRECT EFFECT ON RENAL TUBULAR TRANSPORT OF SODIUM & CHLORIDE INDEPENDENT OF CARBONIC ANHYDRASE INACTIVATION. /THIADIAZIDES/

IRRESPECTIVE OR ULTIMATE MECHANISM, IT APPEARS THAT DIURETIC THIAZIDES RELAX PERIPHERAL ARTERIOLAR SMOOTH MUSCLE. /THIAZIDES/

CARBONIC ANHYDRASE INHIBITOR WITHOUT EXCESSIVE BICARBONATE EXCRETION WITH RESULTANT ACIDOSIS.

For more Mechanism of Action (Complete) data for CHLOROTHIAZIDE (10 total), please visit the HSDB record page.

Biological Half-Life · 2 Einträge

45-120 minutes

Half-life is 1.5 hours. /From Table/

Metabolism/Metabolites · 2 Einträge

Chlorothiazide is not metabolized but is eliminated rapidly by the kidney.

...CHLOROTHIAZIDE...METABOLICALLY STABLE & FOLLOWING IV ADMIN TO...HUMANS...EXCRETED UNCHANGED IN URINE.

FDA Pharmacological Classification · 6 Einträge

77W477J15H

CHLOROTHIAZIDE

Physiologic Effects [PE] - Increased Diuresis

Established Pharmacologic Class [EPC] - Thiazide Diuretic

Chemical Structure [CS] - Thiazides

Chlorothiazide is a Thiazide Diuretic. The physiologic effect of chlorothiazide is by means of Increased Diuresis.

MeSH Pharmacological Classification · 3 Einträge

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Agents that promote the excretion of urine through their effects on kidney function.

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.

Absorption, Distribution and Excretion · 6 Einträge

Rapidly absorbed following oral administration.

Chlorothiazide is not metabolized but is eliminated rapidly by the kidney. After oral doses, 10 to 15 percent of the dose is excreted unchanged in the urine. Chlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.

CHLOROTHIAZIDE IS DISTRIBUTED THROUGHOUT EXTRACELLULAR SPACE & DOES NOT ACCUMULATE IN TISSUES OTHER THAN THE KIDNEY.

ALL OF THE THIAZIDE-LIKE DRUGS CROSS THROUGH THE PLACENTA.

IN NEPHRECTOMIZED ANIMAL, CHLOROTHIAZIDE MAY BE EXCRETED IN THE BILE; IT DOES NOT UNDERGO METABOLIC ALTERATION.

CHLOROTHIAZIDE IN A 1.1 FETAL/MATERNAL CONCN RATIO REQUIRES 60 MIN TO APPEAR IN FETUS... /FROM TABLE/

Cellular LocationsCytoplasm
Metabolite PathwaysChlorothiazide Action Pathway

Verwendung und Herstellung

Uses · 2 Einträge

Diuretic /sodium salt/

MEDICATION (VET):

U.S. Imports · 2 Einträge

(1975) 7.5X10+6 GRAMS (PRINCPL CUSTMS DISTS)

(1976) 1.73X10+7 GRAMS (PRINCPL CUSTMS DISTS)

U.S. Production · 2 Einträge

(1972) GREATER THAN 4.54X10+5 GRAMS

(1975) 4.54X10+5 GRAMS

Consumption PatternsESSENTIALLY 100% AS A MEDICINAL (1976)
Methods of Manufacturing · 2 Einträge

REACTION OF 3-CHLOROANILINE WITH CHLOROSULFONIC ACID FOLLOWED BY TREATMENT WITH AMMONIA TO GIVE 3-CHLORO-4,6-DISULFONAMIDOANILINE WHICH IS THEN HEATED WITH FORMIC ACID

NOVELLO, SPRAGUE, J AM CHEM SOC 79, 2058 (1957); NOVELLO, HINKLEY, US PATENTS 2,809,194; 2,937,169 (1957, 1960, BOTH TO MERCK & CO).

Use Classification · 2 Einträge

Pharmaceuticals -> Diuretics -> Transformation products

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

General Manufacturing Information · 2 Einträge

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide: ACTIVE

A 3 DAY TREATMENT WITHDRAWAL PERIOD SHOULD BE OBSERVED TO AVOID UNTOWARD EFFECTS IN PEOPLE FROM CONSUMING MEAT & ESPECIALLY MILK FROM TREATED ANIMALS.

Anwendungen · 2 Einträge

BeschreibungChlorothiazide is a first-in-class thiazide diuretic initially discovered from its ability to inhibit carbonic anhydrase in vitro. As an antihypertensive agent, this thiazide increases renal excretion of sodium, potassium, chloride, and bicarbonate ions by inhibiting tubular reabsorptive mechanisms.

VerwendenChlorthiazide is a diuretic that causes the body to excrete excess fluid. This drug exhibits strong diuretic action during both acidosis and alkalosis. It is used for arterial hypertension, in edematous syndromes of various genesis, congestive effects in cardiovascular insufficiency, nephrosis and nephritis, and toxicosis. It is especially recommended for hypertonic illnesses. It lowers intraocular pressure in a number of cases.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Ameisensure4-Amino-6-chlorbenzol-1,3-disulfonamid

Nachgelagerte Produkte

Hydrochlorothiazid
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: Chlorothiazide is 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension. It has a role as a diuretic and an antihypertensive agent.